Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2026.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2026.
Financials
Financial year 2026
Prothya Biosolutions Belgium from Brussel, company number BE0462229645, closed financial year 2026 with a result of € -620,353 after tax. For that financial year Prothya Biosolutions Belgium recorded revenue of € 109.1 million and equity of € -2.2 million. Compared with financial year 2024, the result moved from € -1.5 million to € -620,353. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ -2.2 million
▼ € 26.1 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -620,353
▲ 59 % less loss than in 2024
Profit after tax over the fiscal year.
€ 527,428
▼ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3.7 million.
People and assets in 2026
349
▲ 9.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 46.8 million
▲ 33% vs 2024
€ 134,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 204,442
▲ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 112.6 million
▼ 5% vs 2024
€ 4.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 27 years.
€ 9.5 million
▼ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 74 days on average.
€ 7.7 million
▲ 22% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2026 | Change 2024 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 122,682,019 | € 150,371,859 | € 116,839,605 | € 109,086,457 | ▼ 7% |
| Profit after taxes | € 5,151,888 | € -1,522,625 | € -1,510,918 | € -620,353 | ▲ € 890,565 |
| Equity | € 26,861,644 | € 25,339,019 | € 23,828,102 | € -2,239,925 | ▼ € 26.1 million |
| Total debts | € 92,650,041 | € 154,983,732 | € 139,568,788 | € 135,940,696 | ▼ 3% |
| Cash | € 4,252,481 | € 8,310,043 | € 1,070,020 | € 527,428 | ▼ 51% |
| Land & buildings | € 7,721,341 | € 7,142,985 | € 6,302,931 | € 5,442,238 | ▼ 14% |
| Retained profit | € 12,663,125 | € 23,926,924 | € 22,416,006 | € -3,652,020 | ▼ € 26.1 million |
| Bank debt | € 37,937,005 | € 109,717,409 | € 118,755,756 | € 112,615,943 | ▼ 5% |
| Balance sheet total | € 119,824,834 | € 180,502,890 | € 163,907,413 | € 134,385,848 | ▼ 18% |
| Employees (FTE) | 353.8 | 350 | 339.9 | 349 | ▲ 9.1 |
Key figures of Prothya Biosolutions Belgium, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Prothya Biosolutions Belgium?
What happened at Prothya Biosolutions Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 620,353. Source: NBB ↗
- Thomas Gibbs became a director. NBB
- Nadine Jakes became a director. NBB
- Jonathan Wilson became a director. NBB
- Nir EPSTEIN stepped down as director. NBB
- Yuval COHEN stepped down as director. NBB
- Roberto Carlos de campos Morais stepped down as director. NBB
- Yoav HINEMAN stepped down as director. NBB
In short
From € 5.2 million profit in 2022 to € 620,353 loss in 2026.
Paid € 3.7 million in corporate taxes since 2022.
Best year ever: 2022, with € 5.2 million profit.
Pays suppliers within 74 days on average.
A new publication or filing at Prothya Biosolutions Belgium? We notify you, reason included.
Follow Prothya Biosolutions BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Prothya Biosolutions Belgium are Thomas Gibbs, Nadine Jakes and Jonathan Wilson. The shares are held by Accord Plasma B.V. (200%). It owns 100% of Prothya Biosolutions Hungary Korlátolt Felelősségű Társaság and 100% of Prothya Biosolutions Netherlands itself.
Directors
According to the 2026 annual accounts
Thomas Gibbs
Director
since 2025
Nadine Jakes
Director
since 2025
Jonathan Wilson
Director
since 2025
Nir EPSTEIN
Director
since 2020 · until 2025
Yuval COHEN
Director
since 2020 · until 2025
Roberto Carlos de campos Morais
Director
since 2023 · until 2025
Yoav HINEMAN
Director
since 2020 · until 2025
Shareholders
Accord Plasma B.V.
200%
Participations
Prothya Biosolutions Hungary Korlátolt Felelősségű Társaság
100%
Prothya Biosolutions Netherlands
100%
Establishments
Establishment units
Physical locations of this company
de Tyraslaan 109
1120 Brussel
Hanenstraat 148
9255 Buggenhout
Active since 1 January 1998
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0462.229.645
- VAT number
- BE 0462.229.645
- Registered office
- de Tyraslaan 109, 1120 Brussel
- Names & denominations
- Prothya Biosolutions Belgium · “Prothya” of “Prothya Biosolutions”
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 1997
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Bloedbanken, organenbanken en dergelijke
Activiteiten van bloedtransfusiecentra, bloedbanken, spermabanken, organenbanken en dergelijke
Activiteiten van bloedtransfusiecentra en bloed- en organenbanken